Calquence 100 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FDAJE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,375
Award facts
- Contract value 100% obligated
- $22,375.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Calquence 100 mg tablets (quantity: 60 units) on September 10, 2025. This firm fixed-price delivery order has a ceiling value of $22,375.12 and an ultimate completion date of October 1, 2025. The award represents a non-competitive, non-set-aside transaction issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical supply mechanism enabling AmerisourceBergen to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp has demonstrated substantial capability in federal medical procurement through its extensive portfolio of competitively awarded contracts with the DLA and related military healthcare entities. The company's federal contracting history encompasses diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. As a child delivery order under the larger SPE2DX indefinite delivery contract, this award reflects the company's ongoing role as a critical vendor supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The non-set-aside designation indicates the award was issued through open competition, consistent with AmerisourceBergen's standard federal procurement approach.
Quick answers
Who was awarded contract SPE2DB25FDAJE?
SPE2DB25FDAJE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FDAJE worth?
The government has obligated $22,375 on SPE2DB25FDAJE.
Is contract SPE2DB25FDAJE an order under another contract?
Yes. SPE2DB25FDAJE is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FDAJE competed?
The extent of competition for SPE2DB25FDAJE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award